Indicated for adult patients with relapsed or refractory FL after at least 2 prior systemic therapies, COPIKTRA is an oral monotherapy that is

FOCUSED & EFFECTIVE

Approved under accelerated approval based on ORR. Continued approval may be contingent upon confirmatory trials.

FL, follicular lymphoma; ORR, overall response rate